stars 1 stars 2 stars 3

Our mission: To develop safer and more effective immunotherapies through innovations in drug delivery. Avidea Technologies is a leader in the development of polymer-based drug delivery systems with immunotherapeutic applications. Our technology and team are building on more than two decades of pioneering work by our world-class scientific founders and advisors from the National Institutes of Health, the University of Oxford and the Institute for Macromolecular Chemistry. Our founders, advisors and collaborators are experts in the fields of immunology, oncology, vaccines and drug-delivery. We apply the interdisciplinary expertise of our team to overcome key challenges in drug delivery and advance promising immunotherapies to patients in need.

Avidea Technologies Questions

The Avidea Technologies annual revenue was $6 million in 2026.

Avidea Technologies is based in Baltimore, Maryland.

The NAICS codes for Avidea Technologies are [3254, 325414, 32, 32541, 325].

The SIC codes for Avidea Technologies are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users